5% GLUCOSE INJECTION
- Manufacturer
- Baxter Healthcare Corporation | Baxter Healthcare (Shanghai) Co. Ltd.
- Effective date
- 2025-01-24
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 20:41:45
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
HEALTH CARE PROFESSIONAL LETTER



Reporting Adverse Events or Product Quality Issues
To report adverse events associated with these imported products, please call Baxter at 1-866-888-2472, or fax: 1- 800-759-1801. Adverse events or quality problems experienced with the use of these imported products may also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax:
• Complete and submit the report Online:
www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
• Regular mail or Fax: Download form
www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
To report product quality issues associated with these imported products, please contact Baxter Product Surveillance through Baxter - Product Feedback Portal (
productfeedback.baxter.com/%22%20/o%20%22https:/productfeedback.baxter.com/%22%20/t%20%22_blank).
Please also refer to the local prescribing information of the imported product, translated into English, available for:
• 0.9% Sodium Chloride Injection (click
nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723233)
• 5% Glucose Injection (click
nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723235)
• 10% Glucose Injection (click
nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723237)
• 5% Glucose/0.9% Sodium Chloride Injection (click
nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723238)
Please refer to the FDA-approved prescribing information for each drug product listed below:
• 0.9% Sodium Chloride Injection USP (click
www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=f55bd888-5e01-474d-871b-24654c070178&type=pdf&name=f55bd888-5e01-474d-871b-24654c070178)
• 5% Dextrose Injection USP (click
www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5)
• 10% Dextrose Injection USP (click
www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5)
• 5% Dextrose/0.9% Sodium Chloride Injection USP (click
www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf)








PACKAGE INSERT
PACKAGE/LABEL PRINCIPAL DISPLAY PANEL


Baxter Logo Trademark
A6C0062US
GLUCOSE INJECTION
50
100
150
200
250ml
5% GLUCOSE
[Strength] 250ml: 12.5g
[Description] This product is a colorless or almost
colorless clear liquid
[Dosage and Administration] Intravenous drip See the
package insert for details
For details of [Indications], [Adverse Reactions],
[Contraindications], and [Precautions], please refer to the
package insert
[Storage] Store in overwrap
The solution should be clear and should be used
up at one time
Inspect the inner bag by squeezing it and discard
solution if leakage occurs
License Number: H19994071
AA
[Drug Marketing Authorization Holder] [Manufacturer]
Name: Baxter Healthcare (Shanghai) Co., Ltd.
Address: No. 388, Tingzhu Road, Jinshan District, Shanghai
BarCode
(01) 00303389795018
LOT
MFG
EXP
5% Glucose Injection
250ml X 40
LOT S0000000 EXP YYYY-MM
A6C0062US 1C/N LIC H19994071
5% Glucose Injection
250ml X 40
LOT S0000000 EXP YYYY-MM
MFG YYYY-MM-DD 1C/N 0000


Baxter Logo Trademark
A6C0064US
GLUCOSE INJECTION
100
200
300
400
500
600
700
800
900
1000ml
5% GLUCOSE
[Strength] 1000ml: 50g
[Description] This product is a colorless or almost
colorless clear liquid
[Dosage and Administration] Intravenous drip See the
package insert for details
For details of [Indications], [Adverse Reactions],
[Contraindications], and [Precautions], please refer to the
package insert
[Storage] Store in overwrap
The solution should be clear and should be used
up at one time
Inspect the inner bag by squeezing it and discard
solution if leakage occurs
License Number: H19983151
AA
[Drug Marketing Authorization Holder] [Manufacturer]
Name: Baxter Healthcare (Shanghai) Co., Ltd.
Address: No. 388, Tingzhu Road, Jinshan District, Shanghai
BarCode
(01) 00303389801016
LOT
MFG
EXP
5% Glucose Injection
1000ml X 12
LOT S0000000 EXP YYYY-MM
A6C0064US 1C/N LIC H19983151
5% Glucose Injection
1000ml X 12
LOT S0000000 EXP YYYY-MM
MFG YYYY-MM-DD 1C/N 0000
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0338-9795 | GLUCOSE (DEXTROSE ANHYDROUS) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 3 | Unmatched | 20250130_40c99503-14fd-4cd1-b073-c1af7bfa3229.zip |
| 0338-9801 | GLUCOSE (DEXTROSE ANHYDROUS) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 3 | Unmatched | 20250130_40c99503-14fd-4cd1-b073-c1af7bfa3229.zip |
Products#
Every source-derived product name is available through these pages.
- Glucose
- Dextrose Anhydrous
- DEXTROSE MONOHYDRATE
- ANHYDROUS DEXTROSE
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0338-9795 | 0338-9795-01, 0338-9795-40 |
| 0338-9801 | 0338-9801-01, 0338-9801-12 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DEXTROSE MONOHYDRATE | LX22YL083G | ACTIB |
| WATER | 059QF0KO0R | IACT |
| DEXTROSE MONOHYDRATE | LX22YL083G | ACTIB |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ec439628-0781-4170-b4ed-41b2e3f29904 | 40c99503-14fd-4cd1-b073-c1af7bfa3229 | 2025-01-24 | 40c99503-14fd-4cd1-b073-c1af7bfa3229 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.







